FDA.reportPublic FDA data

0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Prefilled Syringe

RxCUI
2719774
RxNorm name
0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Prefilled Syringe
Display name
0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Prefilled Syringe
Full name
0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Prefilled Syringe
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125614ShingrixZoster Vaccine Recombinant, Adjuvanted351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
0280849d-5c78-4a9d-8941-4eab429f6bd80.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Prefilled SyringeSCD23These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
0280849d-5c78-4a9d-8941-4eab429f6bd8varicella zoster virus glycoprotein E, recombinant vaccine 0.5 ML Prefilled SyringePSN23These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
0280849d-5c78-4a9d-8941-4eab429f6bd8varicella zoster virus glycoprotein E, recombinant vaccine 0.5 ML Prefilled SyringeSY23These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
c46e8702-5680-462b-a093-0c7720f77020varicella zoster virus glycoprotein E, recombinant vaccine 0.5 ML Prefilled SyringePSN1These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260306
c46e8702-5680-462b-a093-0c7720f77020varicella zoster virus glycoprotein E, recombinant vaccine 0.5 ML Prefilled SyringeSY1These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260306
c46e8702-5680-462b-a093-0c7720f770200.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Prefilled SyringeSCD1These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260306